# Niclosamide for Familial Adenomatous Polyposis

> **NCT04296851** · PHASE2 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 72 (estimated)

## Conditions studied

- Familial Adenomatous Polyposis

## Interventions

- **DRUG:** Niclosamide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04296851
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-14
- **Primary completion:** 2022-12
- **Final completion:** 2023-02
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2020-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04296851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04296851, "Niclosamide for Familial Adenomatous Polyposis". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT04296851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*